Please assess the completion status of the following clinical trial:

Trial Title: Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participant must be greater than or equal to (≥)18 years of age;~* Participant must be enrolled in Study AG348-C-008.~Exclusion Criteria:~- Participant is enrolled in an Agios-sponsored clinical study involving treatment with a pyruvate kinase activator.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PK Deficiency Diagnosed (Type: None): Participants previously diagnosed with PK deficiency in Study AG348-C-008 (NCT03481738), will receive routine clinical care.

Based on this trial design, predict the completion outcome and termination type (if applicable).